GABA signaling is linked to resistance to immune checkpoint inhibitors in TLS-positive tumors, with non-responders showing increased GABA-related activity.
- 3 cites
Moving in Cancer Cell.
Rebuilt
GABA signaling is linked to resistance to immune checkpoint inhibitors in TLS-positive tumors, with non-responders showing increased GABA-related activity.
Newest first · last 60 days
Disruption of ROS rhythmicity through dual inhibition of IDO1 and AhR extends survival in cancer models, revealing a new therapeutic approach targeting tumor oxidative balance.
Microbial and metabolic signatures, especially microbial metabolites like p-cresols and indoles, drive CNS autoimmunity severity in a mouse model of MS, with diet-microbiome interactions shaping disease outcomes.
Single-cell transcriptomic analysis of 6.3 million nuclei from 1,494 donors reveals shared and distinct molecular signatures across eight brain disorders, including Alzheimer’s disease.
A short-lived anti-PD-L1 antibody was safe and well tolerated in early Alzheimer's disease patients at doses up to 30 mg/kg, supporting further clinical development.
RNA sequencing reveals shared immune-inflammatory, synaptic, and mitochondrial dysfunctions across diverse depressive disorders, advancing understanding of their molecular basis.
Heterogeneity in protein signalling networks, especially reaction coefficients, drives adaptive resistance to CDK4/6 and oestrogen receptor inhibitors, as shown by MDN modelling.
Adolescent depression is linked to 308 plasma proteins involved in immune, metabolic, and extracellular matrix pathways, revealing shared biological signatures across clinical phenotypes.
IL-17A causes premature cortical folding, increased thickness, and accelerated neurogenesis in human fetal brain models, revealing its disruptive role in corticogenesis.
GABA signaling is linked to resistance to immune checkpoint inhibitors in TLS-positive tumors, with non-responders showing increased GABA-related activity.
Journals this month
Moving areas, week to 3 Oct 2026